BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26359796)

  • 1. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
    Gupta S; Verma S; Mantri S; Berman NE; Sandhir R
    Drug Dev Res; 2015 Nov; 76(7):397-418. PubMed ID: 26359796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in heart failure: new targets in disease management.
    Elzenaar I; Pinto YM; van Oort RJ
    Clin Pharmacol Ther; 2013 Oct; 94(4):480-9. PubMed ID: 23852395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Regulators of MicroRNAs in Biomedicine.
    Xia T; Li J; Cheng H; Zhang C; Zhang Y
    Drug Dev Res; 2015 Nov; 76(7):375-81. PubMed ID: 26450362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in neurodegenerative diseases and their therapeutic potential.
    Junn E; Mouradian MM
    Pharmacol Ther; 2012 Feb; 133(2):142-50. PubMed ID: 22008259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases.
    Maniati MS; Maniati M; Yousefi T; Ahmadi-Ahangar A; Tehrani SS
    J Cell Biochem; 2019 Jun; 120(6):8908-8918. PubMed ID: 30663117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in glaucoma and neurodegenerative diseases.
    Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
    J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A miRNA signature of prion induced neurodegeneration.
    Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
    PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the microRNA network cause neurodegenerative disease.
    Hébert SS; De Strooper B
    Trends Neurosci; 2009 Apr; 32(4):199-206. PubMed ID: 19268374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: potentially important regulators for schistosome development and therapeutic targets against schistosomiasis.
    Cheng G; Jin Y
    Parasitology; 2012 Apr; 139(5):669-79. PubMed ID: 22309492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs (miRNAs) in neurodegenerative diseases.
    Nelson PT; Wang WX; Rajeev BW
    Brain Pathol; 2008 Jan; 18(1):130-8. PubMed ID: 18226108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
    Hon LS; Zhang Z
    Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.
    Tomankova T; Petrek M; Gallo J; Kriegova E
    Scand J Immunol; 2012 Feb; 75(2):129-41. PubMed ID: 21988491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
    Tutar L; Tutar E; Özgür A; Tutar Y
    Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as biomarkers of disease onset.
    Ciesla M; Skrzypek K; Kozakowska M; Loboda A; Jozkowicz A; Dulak J
    Anal Bioanal Chem; 2011 Oct; 401(7):2051-61. PubMed ID: 21544542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.